Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Identify index funds that offer best value for retirement by comparing costs, diversification, and potential returns, with practical fund picks.
27,007 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Developers shift from splashy amenities to intentional spaces that foster belonging, a move that also redefines how l...
ClearPoint’s early-2026 earnings signal a busy year ahead. This analysis breaks down revenue, margins, guidance, and ...
Vodafone Group shares jumped about 13% after a dramatic stake reshuffle that makes Vega the largest shareholder. The ...
SpaceX is the darling of space dreams and bold tech bets. This article breaks down what it would take for a public Sp...
New federal data outline where gun thefts concentrate, revealing which states bear the heaviest burden and why safety...
A fresh institutional stake in PENN Entertainment signals shifting sentiment in a dynamic gaming landscape. This deep...
Nu Holdings has fallen about 31% from its peak this year. This article breaks down the business, the pullbacks, and w...
Costco’s latest results show a strong burst in same-store sales, but the stock pulled back. This guide weighs the mom...
An indie comedy topped the weekend box office, outpacing a big-budget action film and highlighting how households are...
Anthropic’s Claude Code is reshaping cost math for developers and businesses. The man behind the tool argues ROI shou...
As mortgage rates stay stubbornly high, UWM Holdings shows resilience by growing market share through manufacturing e...